Chemoinformaics analysis of (11E,13S)-Labda-11,14-Diene-8,13-Diol
| Molecular Weight | 306.49 | nRot | 3 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 13 |
| Exact Molecular Weight | 306.256 | nRing | 2 |
| Solubility: LogS | -4.68 | nHRing | 0 |
| Solubility: LogP | 4.202 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.675 |
| nHD | 2 | BPOL | 34.109 |
| QED | 0.755 |
| Synth | 4.659 |
| Natural Product Likeliness | 2.882 |
| NR-PPAR-gamma | 0.039 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.045 |
| Pgp-sub | 0.002 |
| HIA | 0.009 |
| CACO-2 | -4.4 |
| MDCK | 0.0000269 |
| BBB | 0.772 |
| PPB | 0.826196 |
| VDSS | 1.046 |
| FU | 0.113562 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.395 |
| CYP2c19-inh | 0.217 |
| CYP2c19-sub | 0.77 |
| CYP2c9-inh | 0.239 |
| CYP2c9-sub | 0.247 |
| CYP2d6-inh | 0.116 |
| CYP2d6-sub | 0.044 |
| CYP3a4-inh | 0.933 |
| CYP3a4-sub | 0.687 |
| CL | 5.457 |
| T12 | 0.12 |
| hERG | 0.033 |
| Ames | 0.004 |
| ROA | 0.463 |
| SkinSen | 0.359 |
| Carcinogencity | 0.089 |
| EI | 0.459 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.825 |
| Antiviral | No |
| Prediction | 0.511084 |